Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment
MedComm · 2026-08 · 7 (8)
DOI: 10.1002/mco2.70875 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift MedComm, online erschienen am 22.07.2026. Verfasst von Zhao Ge und 8 weiteren Autor:innen. Beteiligte Einrichtung: First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China. Die Arbeit nennt 202 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Coronary microvascular dysfunction (CMD) is a key contributor to myocardial ischemia and cardiovascular diseases. It is characterized by abnormalities of the coronary microvasculature, leading to impaired myocardial perfusion. Although CMD has a high prevalence in patients with nonobstructive coronary artery disease and is associated with adverse cardiovascular events, its pathogenesis has not yet been fully elucidated. Current diagnostic approaches combine noninvasive and invasive methods, but there remains a lack of effective targeted therapies. This review discusses the epidemiology, pathophysiology, diagnostic strategies, and treatment options for CMD, with a particular focus on the protective role of the neuregulin‐1 (NRG‐1)/v‐erb‐b2 erythroblastic leukemia viral oncogene homolog B (ErbB) signaling pathway. We initially outline how the NRG‐1/ErbB pathway affects endothelial function, ventricular remodeling, oxidative stress, and myocardial angiogenesis, highlighting its potential as a therapeutic target. In addition, we explore emerging evidence that traditional Chinese medicine (TCM) interventions may regulate the NRG‐1/ErbB axis to improve microvascular function and cardiac outcomes. Overall, this review deepens our understanding of the mechanisms underlying CMD and provides new avenues for integrated precision therapies, including TCM, with the aim of improving clinical management and prognosis in patients with CMD.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Teaching Hospital of Tianjin University of Traditional Chinese Medicine Tianjin China.
- National Clinical Research Center for Chinese Medicine Tianjin China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Ge, Z., Zhang, M., Ning, X., Du, Y., Su, L., Wu, X., Zhang, J., Liu, T., & Wang, X. (2026). Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment. MedComm, 7(8). https://doi.org/10.1002/mco2.70875
Vancouver
Ge Z, Zhang M, Ning X, Du Y, Su L, Wu X, et al. Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment. MedComm. 2026;7(8). doi:10.1002/mco2.70875
BibTeX
@article{Ge2026,
author = {Ge, Zhao and Zhang, MaoZe and Ning, Xujin and Du, Yijia and Su, Lishuo and Wu, Xudong and Zhang, Jingyi and Liu, Tongzuo and Wang, Xianliang},
title = {Coronary Microvascular Dysfunction: Epidemiology, Pathophysiology, Diagnosis, and Treatment},
journal = {MedComm},
year = {2026},
volume = {7},
number = {8},
doi = {10.1002/mco2.70875}
}
EUVIMED